Ara h 2 is the best predictor for peanut allergy in adults

Journal of Allergy and Clinical Immunology: In Practice

Volumn 1, Issue 6, 2013, Pages 632-638.e1

  Klemans, Rob J B ^a   Broekman, Henrike C H P ^a   Knol, Edward F ^a   Bruijnzeel Koomen, Carla A F M ^a   Otten, Henny G ^a   Pasmans, Suzanne G M A ^a,b,c   Knulst, André C ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c SOPHIA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

Adults; Ara h 2; Diagnostic prediction model; Food challenge; Peanut allergy; Peanut components; Severity; Skin prick test; Specific IgE; Validation

Indexed keywords

ALLERGEN; ARA H2 ALLERGEN; IMMUNOGLOBULIN E; UNCLASSIFIED DRUG; ARA H 2 ALLERGEN, ARACHIS HYPOGAEA; GLYCOPROTEIN; NAPIN; PLANT ANTIGEN;

ADULT; ANTIBODY DETECTION; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE SEVERITY; FEMALE; HUMAN; IMMUNOLOGY TEST KIT; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PEANUT ALLERGY; PREDICTION; PREDICTIVE VALUE; PRICK TEST; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY; VALIDATION STUDY; ANALYSIS OF VARIANCE; PEANUT HYPERSENSITIVITY; PROCEDURES; SKIN TEST;

2S ALBUMINS, PLANT; ADULT; ANALYSIS OF VARIANCE; ANTIGENS, PLANT; FEMALE; GLYCOPROTEINS; HUMANS; IMMUNOGLOBULIN E; MALE; PEANUT HYPERSENSITIVITY; SENSITIVITY AND SPECIFICITY; SKIN TESTS;

EID: 84887025695     PISSN: 22132198     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaip.2013.07.014     Document Type: Article

References (33)

1. Burks W. Peanut allergy: a growing phenomenon. JClin Invest 2003, 111:950-952.
2. Sicherer S.H., Munoz-Furlong A., Godbold J.H., Sampson H.A. US prevalence of self-reported peanut, tree nut, and sesame allergy: 11-year follow-up. JAllergy Clin Immunol 2010, 125:1322-1326.
3. Kotz D., Simpson C.R., Sheikh A. Incidence, prevalence, and trends of general practitioner recorded diagnosis of peanut allergy in England, 2001 to 2005. JAllergy Clin Immunol 2011, 127:623-630.e1.
4. Grundy J., Matthews S., Bateman B., Dean T., Arshad S.H. Rising prevalence of allergy to peanut in children: data from 2 sequential cohorts. JAllergy Clin Immunol 2002, 110:784-789.
5. Zijlstra W.T., Flinterman A.E., Soeters L., Knulst A.C., Sinnema G., L'Hoir M.P., et al. Parental anxiety before and after food challenges in children with suspected peanut and hazelnut allergy. Pediatr Allergy Immunol 2010, 21:e439-e445.
6. Knibb R.C., Ibrahim N.F., Stiefel G., Petley R., Cummings A.J., King R.M., et al. The psychological impact of diagnostic food challenges to confirm the resolution of peanut or tree nut allergy. Clin Exp Allergy 2012, 42:451-459.
7. Rance F., Abbal M., Lauwers-Cances V. Improved screening for peanut allergy by the combined use of skin prick tests and specific IgE assays. JAllergy Clin Immunol 2002, 109:1027-1033.
8. Sampson H.A., Ho D.G. Relationship between food-specific IgE concentrations and the risk of positive food challenges in children and adolescents. JAllergy Clin Immunol 1997, 100:444-451.
9. Klemans R.J., Otte D., Knol M., Knol E.F., Meijer Y., Gmelig-Meyling F.H., et al. The diagnostic value of specific IgE to Ara h 2 to predict peanut allergy in children is comparable to a validated and updated diagnostic prediction model. JAllergy Clin Immunol 2013, 131:157-163.
10. Nolan R.C., Richmond P., Prescott S.L., Mallon D.F., Gong G., Franzmann A.M., et al. Skin prick testing predicts peanut challenge outcome in previously allergic or sensitized children with low serum peanut-specific IgE antibody concentration. Pediatr Allergy Immunol 2007, 18:224-230.
11. Sporik R., Hill D.J., Hosking C.S. Specificity of allergen skin testing in predicting positive open food challenges to milk, egg and peanut in children. Clin Exp Allergy 2000, 30:1540-1546.
12. DunnGalvin A., Daly D., Cullinane C., Stenke E., Keeton D., Erlewyn-Lajeunesse M., et al. Highly accurate prediction of food challenge outcome using routinely available clinical data. JAllergy Clin Immunol 2011, 127:633-639. e1-3.
13. Bleeker S.E., Moll H.A., Steyerberg E.W., Donders A.R., Derksen-Lubsen G., Grobbee D.E., et al. External validation is necessary in prediction research: a clinical example. JClin Epidemiol 2003, 56:826-832.
14. Toll D.B., Janssen K.J., Vergouwe Y., Moons K.G. Validation, updating and impact of clinical prediction rules: a review. JClin Epidemiol 2008, 61:1085-1094.
15. Altman D.G., Royston P. What do we mean by validating a prognostic model?. Stat Med 2000, 19:453-473.
16. Dang T.D., Tang M., Choo S., Licciardi P.V., Koplin J.J., Martin P.E., et al. Increasing the accuracy of peanut allergy diagnosis by using Ara h 2. JAllergy Clin Immunol 2012, 129:1056-1063.
17. Ebisawa M., Moverare R., Sato S., Maruyama N., Borres M.P., Komata T. Measurement of Ara h 1-, 2-, and 3-specific IgE antibodies is useful in diagnosis of peanut allergy in Japanese children. Pediatr Allergy Immunol 2012, 23:573-581.
18. Eller E., Bindslev-Jensen C. Clinical value of component-resolved diagnostics in peanut allergic patients. Allergy 2013, 68:190-194.
19. Nicolaou N., Custovic A. Quantification of sprecific IgE to whole peanut extract and peanut components in prediction of peanut allergy. JAllergy Clin Immunol 2011, 127:684-685.
20. Nicolaou N., Poorafshar M., Murray C., Simpson A., Winell H., Kerry G., et al. Allergy or tolerance in children sensitized to peanut: prevalence and differentiation using component resolved diagnostics. JAllergy Clin Immunol 2010, 125:191-197. e1-13.
21. Wensing M., Penninks A.H., Hefle S.L., Koppelman S.J., Bruijnzeel-Koomen C.A., Knulst A.C. The distribution of individual threshold doses eliciting allergic reactions in a population with peanut allergy. JAllergy Clin Immunol 2002, 110:915-920.
22. Peeters K.A., Koppelman S.J., van Hoffen E., van der Tas C.W., den Hartog Jager C.F., Penninks A.H., et al. Does skin prick test reactivity to purified allergens correlate with clinical severity of peanut allergy?. Clin Exp Allergy 2007, 37:108-115.
23. Taylor S.L., Hefle S.L., Bindslev-Jensen C., Atkins F.M., Andre C., Bruijnzeel-Koomen C., et al. Aconsensus protocol for the determination of the threshold doses for allergenic foods: how much is too much?. Clin Exp Allergy 2004, 34:689-695.
24. Mueller H.L. Diagnosis and treatment of insect sensitivity. JAsthma Res 1966, 3:331-333.
25. Flinterman A.E., Knol E.F., Lencer D.A., Bardina L., den Hartog Jager C.F., Lin J., et al. Peanut epitopes for IgE and IgG4 in peanut-sensitized children in relation to severity of peanut allergy. JAllergy Clin Immunol 2008, 121:737-743.e10.
26. Hourihane J.O., Grimshaw K.E., Lewis S.A., Briggs R.A., Trewin J.B., King R.M., et al. Does severity of low-dose, double-blind, placebo-controlled food challenges reflect severity of allergic reactions to peanut in the community?. Clin Exp Allergy 2005, 35:1227-1233.
27. Zweig M.H., Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 1993, 39:561-577.
28. Poses R.M., Cebul R.D., Centor R.M. Evaluating physicians' probabilistic judgments. Med Decis Making 1988, 8:233-240.
29. McGee S. Simplifying likelihood ratios. JGen Intern Med 2002, 17:646-649.
30. Moons K.G., Kengne A.P., Grobbee D.E., Royston P., Vergouwe Y., Altman D.G., et al. Risk prediction models: II. External validation, model updating, and impact assessment. Heart 2012, 98:691-698.
31. Applied Regression Analysis 1981, John Wiley and Sons, New York, NY. 2nd ed. N. Draper, H. Smith (Eds.).
32. Astier C., Morisset M., Roitel O., Codreanu F., Jacquenet S., Franck P., et al. Predictive value of skin prick tests using recombinant allergens for diagnosis of peanut allergy. JAllergy Clin Immunol 2006, 118:250-256.
33. Moverare R., Ahlstedt S., Bengtsson U., Borres M.P., van Hage M., Poorafshar M., et al. Evaluation of IgE antibodies to recombinant peanut allergens in patients with reported reactions to peanut. Int Arch Allergy Immunol 2011, 156:282-290.